ArticleBMC oral health2025
Performance of ChatGPT-4o, Gemini Advanced-2.0, and DeepSeek-V3 in the diagnosis and management of temporomandibular disorders.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study evaluated the performance of three large language models (LLMs): ChatGPT-4o (OpenAI, San Francisco, CA, USA), Gemini Advanced-2.0 (Google AI, Mountain View, CA, USA), and DeepSeek-V3 (DeepSeek AI, Hangzhou, China), in diagnosing and recommending managements for temporomandibular joint and masticatory muscle disorders. MATERIALS AND
methods30 clinical scenarios (15 temporomandibular joint-related, 15 masticatory muscle-related) were designed based on literature and clinical expertise. The cases were submitted to each LLM via their respective web platforms. Responses were rated separately for diagnosis and management using a 3-point Likert scale (0 = incorrect, 1 = partially correct, 2 = correct). Two prosthodontists with 5 and 30 years of clinical experience independently scored each response. Data were statistically analyzed, and differences were considered significant at p < 0.05.
resultsNo statistically significant differences were observed in diagnostic scores. However, ChatGPT-4o achieved the highest total scores, with significantly better management performance compared to Gemini Advanced-2.0 and DeepSeek-V3 (p < 0.05). The evaluators’ ratings were consistent in most cases.
conclusionsAmong the evaluated LLMs, ChatGPT-4o demonstrated the highest overall performance, providing more accurate management recommendations compared with the other models. However, the diagnostic reliability varied across different cases. These findings indicate that LLMs may serve as supportive tools in clinical decision-making, particularly for generating preliminary insights. Nevertheless, their current limitations underscore the importance of case-specific professional oversight, and further studies involving real patient cases are essential to better assess their practical reliability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.